" Iron sharpeneth iron " (Prov 27:17): so ends Aquinas in his treatise De perfectione spiritualis. This is surely the reason why the particular Churches and religious orders rightly make so much effort to record accurately and in detail the story of their martyrs. Similarly, it seems to me, that Christ furthers the co-redemptive work of the martyrs when we remember what they did. This is what we mean by anamnesis: the promotion of salvation by remembering the redeeming works of Christ. Yet, He prefers to work along the grain of human nature. " 1 God could, of course, save us without our needing to remember what He has done for us. Indeed, in Latin America there is a class of people referred to as 'the disappeared.' The second reason to 'get personal' rests upon the important place the martyrs hold (in subordination to Christ) as co-redeemers in the words of Tertullian, " the blood of the martyrs is the seed of the Church. This is necessarily the case in an era where the power of the State has become so persuasive that it can (and often did) make people simply disappear. It is very important to personalize the story of the martyrs precisely because so many of those who died for the faith in the past hundred years are faceless and story-less. In doing this, I intend to use both images and anecdotes, and to focus mostly on the martyrs of the modern era. The hope being, that he and other apprentices might learn and imitate. The phrase " to hold a candle " comes from an era before electric or gas lighting, when an apprentice would hold a light over his master's work in order to illuminate it. And yet, while I cannot " hold a candle " in terms of matching their fidelity, there is another way in which I can. To use a phrase in English, I cannot " hold a candle " to giants like St. more Writing about the martyrs is a little daunting when I reflect on my own numerous infidelities to the Lord, even under the most trivial of social pressures. This year’s ASCO meeting highlighted the need to boost diversity in cancer studies.Writing about the martyrs is a little daunting when I reflect on my own numerous infidelities to. ![]() Experts are on… By William Newton How oncology clinical trials can use data to dig deeper on diversity Mapping Endpoints: Most clinical trials for pain still use a zero-to-ten scale as a primary endpoint. By William Newton Fauci: long Covid-19 trial endpoints ‘absolutely have to be standardised’Ĭlinical Trials Arena asks Dr Anthony Fauci about the biggest challenges to selecting long Covid-19 trial endpoints during a… By William Newton Parkinson’s disease: major drug trial results to watch in 2022įour clinical trials in Parkinson’s disease with readouts the second half of 2022 target motor symptom fluctuations and cognitive… By William Newton ‘How badly does it hurt?’ Challenges of measuring pain in clinical trials By William Newton Aristea contemplates Phase III design for rare skin disease drugĪs Aristea develops a palmoplantar pustulosis treatment, US and European regulators indicate different primary endpoint preferences. Alzheimer’s disease: charting amyloid theory trials amidst another controversyĪfter reports of possible image fabrication in studies supporting the amyloid theory for Alzheimer’s disease, we break down the… By William Newton Phase 0 clinical trials: what you need to knowĬlinical Trials Arena breaks down the two most common types of Phase 0 trials, including window of opportunity trials… By William Newton Glioblastoma: are Phase 0 trials a window of opportunity in drug development?ĭespite key advantages to Phase 0 trials in glioblastoma, sponsors have been hesitant to employ the design.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |